What mood stabilizer should be used for a 15‑year‑old female with borderline personality traits who self‑injures by scratching scabs?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Do Not Use Mood Stabilizers for Borderline Personality Traits in Adolescents

Mood stabilizers are not indicated for borderline personality disorder (BPD) or borderline traits in adolescents, and psychotherapy—not medication—should be the first-line treatment. The evidence provided addresses bipolar disorder in youth 1, which is a completely different condition from borderline personality traits with self-injurious behavior.

Critical Distinction: This is NOT Bipolar Disorder

The guidelines you've been provided 1 discuss mood stabilizers for bipolar disorder in adolescents, not borderline personality disorder. These are fundamentally different conditions:

  • Bipolar disorder: Episodic mood disturbances with distinct manic/hypomanic and depressive episodes
  • Borderline personality disorder: Chronic pattern of emotional dysregulation, identity disturbance, interpersonal instability, and impulsive behaviors including self-harm

Applying bipolar treatment guidelines to BPD would be a significant clinical error.

Evidence-Based Approach to BPD in Adolescents

First-Line Treatment: Psychotherapy

Structured psychotherapy is the only evidence-based first-line treatment for adolescent BPD 2. All international guidelines agree on this core recommendation 2. Medication alone does not suffice to manage BPD complexity 3.

Role of Pharmacotherapy (If Any)

When medications are considered for BPD, the evidence is limited and symptom-specific:

For anger/impulsivity symptoms specifically:

  • Mood stabilizers (excluding divalproex) showed large effect sizes for anger reduction (effect size -1.75) 4
  • Lamotrigine and valproate have some supportive evidence in BPD 5, 6, 4
  • However, no medication is FDA-approved for BPD treatment 6, and no drug treats the global psychopathology of BPD 3

For self-harm behavior:

  • NSSI and suicide attempts in BPD are associated with depression comorbidity 7
  • Olanzapine showed a possible increase in self-harming behavior as an adverse effect 5—a critical concern for your patient
  • Antidepressants showed small effects on depression but moderate effects on anger 4

Specific Recommendations for This Case

What to Do:

  1. Refer immediately for evidence-based psychotherapy (DBT, MBT, or other structured BPD-specific therapy) 2
  2. Assess for comorbid major depressive disorder—if present, consider antidepressant treatment for the depression specifically 8
  3. Involve family in treatment 2
  4. Avoid polypharmacy 3

What NOT to Do:

  • Do not prescribe mood stabilizers based on bipolar disorder guidelines
  • Do not use olanzapine (risk of increased self-harm) 5
  • Do not treat with medication alone without psychotherapy 3
  • Do not avoid making the diagnosis due to age—BPD features in adolescence are stable and clinically significant 9

Critical Pitfalls

The biggest mistake would be treating this as bipolar disorder. Scratching scabs and borderline traits represent chronic emotional dysregulation and self-harm behavior, not mood episodes. The evidence you've been given about lithium, valproate, and other mood stabilizers for ages 12+ 1 applies to bipolar disorder, not BPD.

If you prescribe mood stabilizers for borderline traits, you are providing off-label treatment with minimal evidence 5 while delaying access to the only proven treatment: psychotherapy 2.

References

Guideline

practice parameter for the assessment and treatment of children and adolescents with bipolar disorder.

Journal of the American Academy of Child and Adolescent Psychiatry, 2007

Research

Pharmacological interventions for borderline personality disorder.

The Cochrane database of systematic reviews, 2010

Research

Borderline personality disorder: current drug treatments and future prospects.

Therapeutic advances in chronic disease, 2010

Related Questions

What is the recommended evaluation and management of psychotic features in borderline personality disorder?
What are the etiological factors of personality disorder and is there a genetic component?
For a patient with borderline personality disorder (BPD) under consideration, bipolar disorder ruled out, and persistent post‑traumatic stress disorder (PTSD) and insomnia, what alternative pharmacologic options can improve mood stability if escitalopram is ineffective?
What medication options are appropriate for a 21-year-old woman with anxiety, depressive symptoms, a history of trauma, borderline personality traits, prominent anger-management difficulties, and cannabis (THC) use, without significant past medical history?
What medication regimen is recommended for a patient with borderline personality disorder and severe depression?
In a patient on basal‑bolus insulin and tirzepatide, should insulin be titrated by increasing or decreasing the basal dose by 2 units (and the bolus dose by 1‑2 units) based on glucose readings?
What is the appropriate diagnostic and therapeutic approach for a 36-year-old man presenting with a single 6‑month‑duration patch on his beard?
When should repaglinide (a rapid‑acting insulin secretagogue) and pioglitazone (an insulin‑sensitizing thiazolidinedione) be considered for patients with type 2 diabetes?
Does ischemic priapism significantly change after 48 hours?
In priapism lasting 48 hours, can the penis return to a normal flaccid appearance on its own?
Does ischemic priapism typically present with a full-length, rigid erection?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.